600 Researchers, 340 Papers: Oman's Medical AI Push Gets a Stage

Oman's largest academic hospital network put artificial intelligence at the heart of its research agenda this week, as the University Medical City (UMC) hosted its second annual Research Day in Muscat, drawing 600 researchers, academics and health professionals and showcasing 340 submitted papers on everything from AI-assisted oncology to organ transplantation.

🔑 Key Takeaways

• UMC's "From Evidence to Excellence" Research Day attracted over 600 participants and 340 submitted research papers, according to Oman Observer.
• Fifteen papers were selected for oral presentation and 60 for scientific posters, spanning 20 research fields including AI and machine learning applications in precision medicine, cardiology and infectious diseases.
• Georgetown University's Professor Zobair Younossi delivered a keynote on how AI can accelerate drug discovery, genomic analysis and clinical trial design.
• UMC disclosed that its affiliated institutions published 353 peer-reviewed papers in 2025, a 14% rise on 2024, plus 203 more in the first half of 2026, and launched 46 new clinical trials over the past three years, per Times of Oman.
• Awards were handed out for Best Emerging Researcher and Best Poster across basic, educational, institutional and health-policy research categories.

🏥 What Happened

The University Medical City, the Royal Decree-established body that absorbed Sultan Qaboos University Hospital, the Oman National Centre for Haematology and Marrow Transplantation, and the Sultan Qaboos Comprehensive Cancer Care and Research Centre, held its Research Day under the theme "From Evidence to Excellence," under the auspices of Sayyid Saud bin Hilal al Busaidi, Minister of Culture, Sports and Youth, and patronised by Dr Hilal bin Ali al Sabti, Minister of Health, as reported by Oman Observer.

Of the 340 papers submitted for consideration this year, only 15 made the cut for oral presentation and 60 for scientific posters, according to both Oman Observer and Times of Oman. Research spanned 20 fields, with AI and machine learning applications running through several of them: predicting health complications, precision medicine, oncology, cardiovascular disease, organ transplantation, infectious diseases, patient safety and clinical pharmacy.

🤖 AI as the Headline Theme

The scientific programme's centrepiece was a keynote from Professor Zobair Younossi, Chairman of the Global Council on Metabolic Dysfunction-Associated Steatotic Liver Disease and a professor of medicine at Georgetown University, who argued that AI is now indispensable to modern clinical research.

According to Times of Oman, Younossi pointed to drug discovery and development, genomic and big-data analysis, clinical trial optimisation, disease-progression modelling, and AI-assisted scientific writing as areas where the technology is already reshaping research workflows.

Dr Siham bint Salim al Sinani, CEO of the University Medical City, struck a note of caution about how success should be measured, telling attendees that research value "isn't measured solely by studies completed, but by contribution to developing thinking and practice," as paraphrased by Times of Oman. It is a useful corrective for a sector where AI hype often outpaces measurable clinical impact.

📊 The Numbers Behind the Headlines

Beyond the single-day event, UMC used the occasion to disclose broader research output figures that give a sense of scale. Its affiliated institutions published 353 papers in peer-reviewed journals in 2025, a 14% increase over 2024, and had already logged 203 publications in the first half of 2026, according to Times of Oman. The institution also reported 46 new clinical trials launched over the past three years.

Awards on the day recognised the top three oral presentations and posters, Best Emerging Researcher honours, and Best Poster prizes across basic, educational, institutional and health-policy research categories, per Oman Observer.

🎓 Part of a Wider Research Push

The Research Day lands in a year when Oman's universities have been unusually vocal about research output, from the University of Technology and Applied Sciences' record 2025/26 tally of patents and start-ups to Sultan Qaboos University students placing among the world's best AI researchers abroad. UMC's disclosure of publication and clinical-trial counts fits that same pattern of Omani institutions using data, rather than ceremony alone, to demonstrate research momentum tied to Oman Vision 2040's knowledge-economy goals.

🇴🇲 Why This Matters for Oman

Healthcare is one of the sectors where AI's practical value is easiest to prove, and Oman's push to apply it inside its own teaching hospitals matters for three reasons. First, it signals that AI adoption in Oman is moving beyond government digital services and fintech into clinical research, a field where better trial design and faster genomic analysis can directly affect patient care. Second, the publication and clinical-trial figures give outside observers, including prospective research partners and investors, a concrete benchmark for UMC's output rather than anecdotal claims. Third, events like this build the pipeline of Omani researchers trained to use AI tools in their own studies, reinforcing the country's broader ambition to grow a homegrown research and innovation base rather than simply importing foreign AI systems.